CureSearch is pleased to announce the appointment of John Polson, Chairman and Managing Partner of Fisher Phillips, to our Board of Directors.
With over 30 years of legal and leadership experience, Polson brings a wealth of expertise to CureSearch. As Chairman and Managing Partner of Fisher Phillips, an international labor and employment law firm, he oversees the strategic direction and operations of the firm’s 41 offices worldwide. Under his leadership, Fisher Phillips has flourished, earning recognition among the most respected legal publications, including The Best Lawyers in America and The Legal 500.
“I am honored to join CureSearch in their fight to end childhood cancer,” said Polson. “This is a cause that is very close to my heart, and I look forward to helping drive the organization’s critical work in advancing research and providing hope to children and families affected by cancer.”
Polson’s dedication to the cause of childhood cancer has been demonstrated through his leadership of Fisher Phillips’ charitable initiatives. The firm’s philanthropic arm, FP Cares, raised $200,000 for CureSearch and participated in the “Notes of Hope” campaign, where firm employees wrote thousands of heartfelt letters to children undergoing cancer treatment. In recognition of the firm’s significant impact, CureSearch awarded Fisher Phillips the “Champion for Cures” award.
Polson’s appointment to the CureSearch Board comes at a crucial moment as we are achieving remarkable progress in our mission to fast-track the development of innovative treatments for pediatric cancers. Currently, 60% of CureSearch-funded preclinical projects are advancing to clinical trials—far exceeding the national average of 8% for cancer trials.
“We are thrilled to welcome John Polson to the CureSearch Board of Directors,” said Kay Koehler, President & CEO of CureSearch for Children’s Cancer. “John’s proven leadership, deep commitment to social impact, and ability to build strong relationships will be invaluable as we continue our work to bring life-saving treatments to children with cancer. His experience and vision will help us take our mission to the next level, and we are honored to have him by our side in the fight to end childhood cancer.”
Polson joins a distinguished group of business leaders, childhood cancer experts, and advocates on the CureSearch Board, all working together to ensure that every child diagnosed with cancer has access to the most advanced and effective treatments available. His leadership and expertise will play a crucial role in helping us continue to transform the landscape of pediatric cancer research.
